Telomir Pharmaceuticals (TELO) Debt Ratio (2023 - 2026)
Telomir Pharmaceuticals' (TELO) Debt Ratio stood at 0.03 in Q2 2026.
Powered by 
Analysis
Telomir Pharmaceuticals (TELO) Debt Ratio (2023 - 2026) Analysis & Trends
For FY2023, Telomir Pharmaceuticals' Debt Ratio came in at 0.02.
- The Q2 2026 figure is the lowest quarterly Debt Ratio since Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Telomir Pharmaceuticals | 82.53 Mn | 82.53 Mn | - | 0.03 |
API Access
Telomir Pharmaceuticals Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=TELO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "TELO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=TELO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();